Brief: Sutro Biopharma Q1 Revenue USD 13.008 Million
13/05/2024 21:30
May 13 (Reuters) - Sutro Biopharma Q1 operating income USD -56.591 million. * Q1 operating expenses USD 69.599 million * Q1 net income USD -58.213 million * Q1 basic EPS USD -0.95
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates